LXRX

usequities
12/03/2022 03:22 AM

@TheMarketsDaily: Lexicon Pharmaceuticals $LXRX Rating Lowered to Sell at https://t.co/CWhpg4D2fv https://t.co/u0n08hfhdm

LXRX

usequities
11/24/2022 03:00 AM

@AmericanBanking: Lexicon Pharmaceuticals $LXRX Upgraded at https://t.co/lM3EpoP1Ng https://t.co/soQMcQvBTl #stocks

LXRX

usequities
11/24/2022 03:00 AM

@AmericanBanking: Lexicon Pharmaceuticals $LXRX Upgraded at https://t.co/lM3EpoP1Ng https://t.co/soQMcQvBTl #stocks

LXRX

usequities
11/14/2022 01:58 AM

@AmericanBanking: Lexicon Pharmaceuticals $LXRX Upgraded at https://t.co/lM3EpoxYLg https://t.co/iA5oavibIq #stocks

LXRX

usequities
11/14/2022 01:58 AM

@AmericanBanking: Lexicon Pharmaceuticals $LXRX Upgraded at https://t.co/lM3EpoxYLg https://t.co/iA5oavibIq #stocks

LXRX

usequities
09/16/2022 03:20 AM

@Tickeron: $LXRX in Downtrend: its price may drop because broke its higher Bollinger Band on August 15, 2022. View odds for th… https://t.co/t9hNkfejEE

LXRX

usequities
08/22/2022 12:54 PM

@storminvestor: Lexicon Pharmaceuticals $LXRX Shares Down 7.5% https://t.co/Iz9tZEHHM7 #markets

LXRX

usequities
08/22/2022 12:54 PM

@storminvestor: Lexicon Pharmaceuticals $LXRX Shares Down 7.5% https://t.co/Iz9tZEHHM7 #markets

LXRX

usequities
08/17/2022 05:40 PM

@Tickeron: $LXRX in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on August 15, 2022… https://t.co/OVyLeK33fr

LXRX

usequities
08/17/2022 05:40 PM

@Tickeron: $LXRX in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on August 15, 2022… https://t.co/OVyLeK33fr

LXRX

usequities
08/15/2022 03:17 PM

@Tickeron: $LXRX in +13.5% Uptrend, growing for three consecutive days on August 3, 2022. View odds for this and other indicat… https://t.co/Q0HOvQS5St

LXRX

usequities
08/15/2022 03:17 PM

@Tickeron: $LXRX in +13.5% Uptrend, growing for three consecutive days on August 3, 2022. View odds for this and other indicat… https://t.co/Q0HOvQS5St

LXRX

usequities
08/02/2022 01:33 PM

@MarketCurrents: $LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.16 in-line, revenue of $0.04M misses by $0.06M https://t.co/mIB4RFP7jM

LXRX

usequities
07/28/2022 04:42 AM

@MarketCurrents: $LXRX - Lexicon Pharma slumps on pricing $85M stock offering and concurrent private placement https://t.co/Rukcbieo1I

LXRX

usequities
07/28/2022 04:42 AM

@MarketCurrents: $LXRX - Lexicon Pharma slumps on pricing $85M stock offering and concurrent private placement https://t.co/Rukcbieo1I